142 related articles for article (PubMed ID: 9078387)
21. Similarities and differences in the RNase H activities of human immunodeficiency virus type 1 reverse transcriptase and Moloney murine leukemia virus reverse transcriptase.
Gao HQ; Sarafianos SG; Arnold E; Hughes SH
J Mol Biol; 1999 Dec; 294(5):1097-113. PubMed ID: 10600369
[TBL] [Abstract][Full Text] [Related]
22. Mutations in the RNase H primer grip domain of murine leukemia virus reverse transcriptase decrease efficiency and accuracy of plus-strand DNA transfer.
Mbisa JL; Nikolenko GN; Pathak VK
J Virol; 2005 Jan; 79(1):419-27. PubMed ID: 15596835
[TBL] [Abstract][Full Text] [Related]
23. Construction of an enzymatically active ribonuclease H domain of human immunodeficiency virus type 1 reverse transcriptase.
Stahl SJ; Kaufman JD; Vikić-Topić S; Crouch RJ; Wingfield PT
Protein Eng; 1994 Sep; 7(9):1103-8. PubMed ID: 7530360
[TBL] [Abstract][Full Text] [Related]
24. RNA-cDNA hybrids mediate transposition via different mechanisms.
Todd LA; Hall AC; Pietrobon V; Chan JNY; Laflamme G; Mekhail K
Sci Rep; 2020 Sep; 10(1):16034. PubMed ID: 32994470
[TBL] [Abstract][Full Text] [Related]
25. Ty1 reverse transcriptase does not read through the proposed 2',5'-branched retrotransposition intermediate in vitro.
Pratico ED; Silverman SK
RNA; 2007 Sep; 13(9):1528-36. PubMed ID: 17652136
[TBL] [Abstract][Full Text] [Related]
26. A 5'-3' long-range interaction in Ty1 RNA controls its reverse transcription and retrotransposition.
Cristofari G; Bampi C; Wilhelm M; Wilhelm FX; Darlix JL
EMBO J; 2002 Aug; 21(16):4368-79. PubMed ID: 12169639
[TBL] [Abstract][Full Text] [Related]
27. Double-stranded RNA-dependent RNase activity associated with human immunodeficiency virus type 1 reverse transcriptase.
Ben-Artzi H; Zeelon E; Gorecki M; Panet A
Proc Natl Acad Sci U S A; 1992 Feb; 89(3):927-31. PubMed ID: 1371014
[TBL] [Abstract][Full Text] [Related]
28. Cleavage of double-stranded RNA by RNase HI from a thermoacidophilic archaeon, Sulfolobus tokodaii 7.
Ohtani N; Yanagawa H; Tomita M; Itaya M
Nucleic Acids Res; 2004; 32(19):5809-19. PubMed ID: 15520465
[TBL] [Abstract][Full Text] [Related]
29. Identification of the first archaeal Type 1 RNase H gene from Halobacterium sp. NRC-1: archaeal RNase HI can cleave an RNA-DNA junction.
Ohtani N; Yanagawa H; Tomita M; Itaya M
Biochem J; 2004 Aug; 381(Pt 3):795-802. PubMed ID: 15115438
[TBL] [Abstract][Full Text] [Related]
30. Sequence and comparative structural analysis of the murine leukaemia virus amphotropic strain 4070A RNase H domain.
Ey PL; Freeman NL; Bela B; Haese PM; Li P; McInnes JL
Arch Virol; 1999; 144(11):2185-99. PubMed ID: 10603172
[TBL] [Abstract][Full Text] [Related]
31. Mutational analysis of the DNA polymerase and ribonuclease H activities of human immunodeficiency virus type 2 reverse transcriptase expressed in Escherichia coli.
Hizi A; Tal R; Hughes SH
Virology; 1991 Jan; 180(1):339-46. PubMed ID: 1701948
[TBL] [Abstract][Full Text] [Related]
32. Amino acid substitutions away from the RNase H catalytic site increase the thermal stability of Moloney murine leukemia virus reverse transcriptase through RNase H inactivation.
Konishi A; Hisayoshi T; Yokokawa K; Barrioluengo V; Menéndez-Arias L; Yasukawa K
Biochem Biophys Res Commun; 2014 Nov; 454(2):269-74. PubMed ID: 25450388
[TBL] [Abstract][Full Text] [Related]
33. Polypurine tract formation by Ty1 RNase H.
Wilhelm M; Uzun O; Mules EH; Gabriel A; Wilhelm FX
J Biol Chem; 2001 Dec; 276(50):47695-701. PubMed ID: 11595735
[TBL] [Abstract][Full Text] [Related]
34. Preparation and characterization of the RNase H domain of Moloney murine leukemia virus reverse transcriptase.
Nishimura K; Yokokawa K; Hisayoshi T; Fukatsu K; Kuze I; Konishi A; Mikami B; Kojima K; Yasukawa K
Protein Expr Purif; 2015 Sep; 113():44-50. PubMed ID: 25959458
[TBL] [Abstract][Full Text] [Related]
35. Capsid-targeted viral inactivation can eliminate the production of infectious murine leukemia virus in vitro.
VanBrocklin M; Federspiel MJ
Virology; 2000 Feb; 267(1):111-23. PubMed ID: 10648188
[TBL] [Abstract][Full Text] [Related]
36. Functional differences between the human LINE retrotransposon and retroviral reverse transcriptases for in vivo mRNA reverse transcription.
Dhellin O; Maestre J; Heidmann T
EMBO J; 1997 Nov; 16(21):6590-602. PubMed ID: 9351839
[TBL] [Abstract][Full Text] [Related]
37. Expression of hepatitis B virus polymerase in Ty1-his3AI retroelement of Saccharomyces cerevisiae.
Qadri I; Siddiqui A
J Biol Chem; 1999 Oct; 274(44):31359-65. PubMed ID: 10531336
[TBL] [Abstract][Full Text] [Related]
38. Replication of the Escherichia coli chromosome in RNase HI-deficient cells: multiple initiation regions and fork dynamics.
Maduike NZ; Tehranchi AK; Wang JD; Kreuzer KN
Mol Microbiol; 2014 Jan; 91(1):39-56. PubMed ID: 24164596
[TBL] [Abstract][Full Text] [Related]
39. Mutations of a conserved residue within HIV-1 ribonuclease H affect its exo- and endonuclease activities.
Wöhrl BM; Volkmann S; Moelling K
J Mol Biol; 1991 Aug; 220(3):801-18. PubMed ID: 1714505
[TBL] [Abstract][Full Text] [Related]
40. In vitro analysis of human immunodeficiency virus type 1 minus-strand strong-stop DNA synthesis and genomic RNA processing.
Driscoll MD; Golinelli MP; Hughes SH
J Virol; 2001 Jan; 75(2):672-86. PubMed ID: 11134281
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
